Valuation: Medpace Holdings, Inc.

Market Cap 17.37B 15.46B 14.33B 12.99B 24.41B 1,646B 24.82B 172B 67.56B 861B 65.17B 63.81B 2,748B P/E 2026 *
35.4x
P/E 2027 * 32.5x
Enterprise Value 16.59B 14.77B 13.69B 12.4B 23.31B 1,572B 23.7B 164B 64.52B 823B 62.24B 60.95B 2,624B EV / Sales 2026 *
5.82x
EV / Sales 2027 * 5.32x
Free-Float
81.03%
Yield 2026 *
-
Yield 2027 * -
1 day+0.45%
1 week+2.06%
Current month-0.28%
1 month+1.65%
3 months+17.90%
6 months+17.79%
Current year+10.82%
1 week 610.05
Extreme 610.05
637.15
1 month 587.38
Extreme 587.385
642.64
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 30/06/1992
Director of Finance/CFO 51 31/07/2021
Chief Tech/Sci/R&D Officer 65 31/08/2017
Director TitleAgeSince
Chairman 69 30/06/1992
Director/Board Member 55 30/06/2016
Director/Board Member 72 30/06/2016
Date Insider Type Main position Quantity % Market Cap. Importance
12/10/26 Exercice

Chief Operating Officer

6,000 0.0215%
07/10/26 Exercice

Chief Operating Officer

4,000 0.0143%
30/09/26 Sell

Chief Executive Officer

-21,966 0.0787%
Change 5-day change 1-year change 3-year change Capi.($)
+0.45%+2.06%+14.33%+171.51% 17.37B
+0.79%-6.16%+49.32%+74.50% 66.34B
-1.12%+5.36%+10.46%+88.28% 52.92B
+0.13%+4.66%+7.28%+73.21% 54.82B
+0.74%+2.75%+26.31%+45.29% 44.09B
+3.87%+10.15%+20.69%+132.73% 43.72B
+7.91%+4.30%+263.91%+602.72% 42.13B
-0.40%+9.85%+17.04%+59.17% 33.96B
-1.30%-0.68%+37.15%+7.04% 26.17B
+0.31%+5.08%+35.92%+25.76% 23.37B
Average +1.13%+4.67%+48.24%+128.02% 40.49B
Weighted average by Cap. +1.24%+4.73%+49.51%+129.90%

Financials

2026 *2027 *
Net sales 2.85B 2.54B 2.35B 2.13B 4.01B 270B 4.07B 28.23B 11.09B 141B 10.7B 10.48B 451B 3.03B 2.7B 2.5B 2.27B 4.26B 287B 4.33B 30.02B 11.79B 150B 11.37B 11.14B 480B
Net income 503M 447M 415M 376M 706M 47.62B 718M 4.98B 1.95B 24.92B 1.89B 1.85B 79.5B 546M 486M 451M 408M 768M 51.76B 780M 5.41B 2.12B 27.08B 2.05B 2.01B 86.4B
Net Debt -780M -694M -644M -583M -1.1B -73.91B -1.11B -7.72B -3.03B -38.68B -2.93B -2.87B -123B -1.24B -1.11B -1.03B -930M -1.75B -118B -1.78B -12.31B -4.84B -61.66B -4.67B -4.57B -197B
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
20/10/26 US$622.43 +0.45% 403,823
19/10/26 US$619.66 +0.19% 247,111
16/10/26 US$618.47 -1.61% 325,148
15/10/26 US$628.60 +1.94% 391,773
14/10/26 US$616.63 +1.11% 311,258
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
622.43USD
Average target price
595.92USD
Spread / Average Target
-4.26%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medpace Holdings, Inc.
  1. Stock Market
  2. Stocks
  3. MEDP Stock